The Relationship Between The Rationality Of Prescribing And The Quality Of Life Of Hypertension Patients At The Central Siantan Health Center In Pontianak
Abstract
Hypertension is a silent killer disease that can affect the patient's quality of life. There is a need for rational treatment to achieve the success of therapy and the desired quality of life. This study aims to determine the relationship between the rationality of prescribing and the quality of life of hypertensive patients. The study design was an observational cohort. Data were obtained from hypertensive patients at the Puskesmas Siantan Tengah Pontianak who met the inclusion criteria in June-July 2021 using a prospective purposive sampling and collected from medical records, EQ5D5L and VAS questionnaires. The results of the study on 101 samples were obtained; the rationality of prescribing antihypertensive drugs was rational, with the percentage of rationality being the appropriate indication 87,12%; appropriate drug 87.12%; appropriate patient 88.11%; and appropriate dose 88.11%. In addition, 28 patients (27.72%) did not have a problem with the five dimensions with the highest EQ5D5L index of 1,000, while the quality of life, as measured by VAS, had a median value of 60. The results of the Pearson chi-square test showed that there was a relationship between the rationality of prescription and quality of life for hypertensive patients with a significance value ≥ 0.05 using the EQ5D5L (p = 0.688) and VAS (p = 0.583) questionnaires. Conclusion: there is no significant relationship between the rationality of prescribing and the quality of life of hypertensive patients, both using the EQ5D5L and VAS questionnaires.
References
E. Y. Sukandar, R. Adrajati, J. I.
Sigit, I. K. Adnyana, A. P. Setiadi,
and Kusnandar, Iso Farmakoterapi.
Chi-Square Tests
Value df Asymp.
Sig. (2-
sided)
Exact
Sig.
(2-
sided)
Exact
Sig.
(1-
sided)
Pearson
Chi-
Square
.301a 1 .583
Jakarta: PT. ISFI Penerbitan, 2008.
E. Triyanto, Pelayanan
Keperawatan Bagi Penderita
Hipertensi Secara Terpadu.
Yogyakarta: Graha Ilmu, 2014.
E. K. R. Sudarsono, J. F. A. Sasmita,
A. B. Handyasto, N.
Kuswantiningsih, and S. S.
Arissaputra, “Peningkatan
Pengetahuan Terkait Hipertensi
Guna Perbaikan Tekanan Darah
pada Pemuda di Dusun Japanan,
Margodadi, Seyegan, Sleman,
Yogyakarta,” J. Pengabdi. Kpd.
Masy. (Indonesian J. Community
Engag., vol. 3, no. 1, pp. 26–38,
, doi: 10.22146/jpkm.25944.
A. Yonata and A. S. P. Pratama,
“Hipertensi sebagai Faktor Pencetus
Terjadinya Stroke,” J. Major., vol. 5,
no. 3, pp. 17–21, 2016.
Kementrian Kesehatan RI, Laporan
Provinsi Kalimantan Barat
RISKESDAS 2018. Kalimantan
Barat: Kementrian Kesehatan RI,
Dinas Kesehatan Kota Pontianak,
Profil Kesehatan Kota Pontianak.
Kota Pontianak: Dinas Kesehatan
Kota Pontianak, 2017.
S. N. Ramadhani, “Studi Literatur :
Analisis Faktor Penyebab Tingginya
Angka Rujukan di Puskesmas Pada
Era JKN,” Media Gizi Kesmas, vol.
, no. 2, 2020.
S. E. Y. N. Khotimah and L.
Musnelina, “Evaluasi Penggunaan
Obat Antihipertensi Pada Pasien
Hipertensi Primer Usia ≤ 45 Tahun
Di Instalasi Rawat Jalan Rumah
Sakit Umum Daerah ( RSUD ) Kota
Depok,” Sainstech Farma ISSN
-7816, vol. 9, no. 1, pp. 30–34,
S. Aryzki, N. Aisyah, H. Hutami,
and B. Wahyusari, “Evaluasi
Rasionalitas Pengobatan Hipertensi
Di Puskesmas Pelambuan Banjar
Masin Tahun 2017,” J. Ilm.
Manuntung, vol. 4, no. 2, p. 119,
, doi: 10.51352/jim.v4i2.191.
M. van Reenen et al., EQ-5D : EQ-
D-5L User Guide. 2019.
A. Sari, N. Yuni Lestari, and D.
Aryani Perwitasari, “Validasi ST
European Quality OF Life-5
Dimensions (EQ-5D) Versi
Indonesia Pada Pasien Hipertensi Di
Puskesmas Kotagede II
Yogyakarta,” Pharmaciana, vol. 5,
no. 2, 2015, doi:
12928/pharmaciana.v5i2.2483.
B. Lapau, Metode Penelitian
Kesehatan : Metode Ilmiah
Penulisan Skripsi, Tesis, dan
Disertasi. Jakarta: Yayasan Pustaka
Obor Indonesia, 2015.
L. Sundari and M. Bangsawan,
“Faktor-Faktor Yang Berhubungan
Dengan Kejadian Hipertensi,” J.
Keperawatan, vol. 11, no. 2, 2015,
doi: 10.36565/jab.v8i1.105.
E. Syahrini, “Faktor-Faktor Risiko
Hipertensi Primer Di Puskesmas
Tlogosari Kulon Kota Semarang,” J.
Kesehat. Masy. Univ. Diponegoro,
vol. 1, no. 2, p. 18704, 2012.
T. Taslim and Y. A. Betris,
“Gambaran Pemberian Obat pada
Penderita Hipertensi di Puskesmas
Rawang,” J. Ris. Kefarmasian
Indones., vol. 2, no. 2, pp. 72–79,
Nafrialdi, Antihipertensi Dalam
Farmakologi dan Terapi Edisi 5.
Jakarta: Departemen farmakologi
dan Terapeutik, Fakultas
Kedokteran Universitas Indonesia,
A. V. Chobanian et al., “Seventh
report of the Joint National
Committee on Prevention,
Detection, Evaluation, and
Treatment of High Blood Pressure,”
Hypertension, vol. 42, no. 6, pp.
–1252, 2003, doi:
1161/01.HYP.0000107251.4951
c2.
U. Sodiqoh, A. Ismunandar, and L.
H. Maulana, “Analisis Rasionalitas
Penggunaan Obat pada Pasien
Hipertensi di Puskesmas Bumiayu
Tahun 2021,” Pharm PJ, vol. 1, no.
, pp. 1–7, 2021.
P. A. James, S. Oparil, B. L. Carter,
W. C. Cushman, C. Dennison, and J.
Handler, “2014 Evidence-Based
Guideline for the Management of
High Blood Pressure in Adults
Report From the Panel Members
Appointed to the Eighth Joint
National Committee (JNC 8),” vol.
, no. 5, pp. 507–520, 2014, doi:
1001/jama.2013.284427.
S. Alaydrus, “Profil Penggunaan
Obat pada pasien Hipertensi di
Puskesmas Marawola Periode
Januari - Maret 2017,” J. Mandala
Pharmacon Indones., vol. 3, no. 2,
pp. 110–118, 2017.
D. Darwis, Y. Rikmasari, and W. N.
Santi, “Rasionalitas Penggunaan
Obat dan Kepatuhan Pasien
Hipertensi Di Puskesmas Mekarsari
Dan Puskesmas Lebubg Bandung
Kabupaten Ogan Ilir Pada Bulan
Mei-Juli 2016,” J. Ilm. Bakti Farm.,
vol. 3, no. 2, pp. 7–18, 2018.
M. A. Yuswar, R. Susanti, and N. S.
Az-zahra, “Pengukuran Kualitas
Hidup Pasien Pengguna
Antihipertensi dengan European
Quality of Life 5 Dimensions
(EQ5D) Questionnaire dan Visual
Analog Scale (VAS) M,” J. Sains
Kes, vol. 2, no. 2, pp. 93–99, 2019.
M. A. Yuswar, N. U. Purwanti, and
W. Zuraida, “Pengukuran Kualitas
Hidup Pasien Hipertensi di
Puskesmas Perumnas I Kota
Pontianak yang Menggunakan
Antihipertensi melalui EQ5D
Questionnaire dan VAS,” Pustaka
Kesehat., vol. 7, no. 2, p. 65, 2019,
doi: 10.19184/pk.v7i2.19115.
R. A. Farha, A. Saleh, and S.
Aburuz, “The impact of drug related
problems on health-related quality of
life among hypertensive patients in
Jordan,” Pharm. Pract. (Granada).,
vol. 15, no. 3, pp. 1–8, 2017.
A. Sari, Lolita, and Fauzia,
“Puskesmas Mergangsan
Yogyakarta Menggunakan Europan
Quality of Life 5 Dimensions (
EQ5D ) Questionnaire dan Visual
Analog Scale ( VAS ),” J. Ilm. Ibnu
Sina, vol. 2, no. 1, pp. 1–12, 2017.
.png)
